Barely Significant
← all excerpts

Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT).

BMJ Open · 2014 · PMC4010821 · PMID 24785401

1
hedged sentence
closest p
boldest claim

The sentences

highly significantno p-value reported
7 Two large randomised controlled trials (RCTs) also found highly significant improvements in total Inflammatory Bowel Disease Questionnaire (IBDQ) scores and Short Form-36 physical and mental component scores for infliximab patients at 8 weeks when compared with placebo. 8 Current UK National Institute for Health and Care Excellence (NICE) guidelines allow the use of inflix

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.